DOW INC (2OY.DE) Stock Fundamental Analysis
Europe - FRA:2OY - US2605571031 - Common Stock
21.2 EUR
+0.5 (+2.42%)
Taking everything into account, 2OY scores 3 out of 10 in our fundamental rating. 2OY was compared to 65 industry peers in the Chemicals industry. 2OY has a bad profitability rating. Also its financial health evaluation is rather negative. 2OY is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year 2OY was profitable.
In the past year 2OY had a positive cash flow from operations.
2OY had positive earnings in each of the past 5 years.
Each year in the past 5 years 2OY had a positive operating cash flow.
1.2 Ratios
The Return On Assets of 2OY (-1.69%) is worse than 63.08% of its industry peers.
2OY has a Return On Equity of -5.77%. This is in the lower half of the industry: 2OY underperforms 64.62% of its industry peers.
2OY's Return On Invested Capital of 1.27% is on the low side compared to the rest of the industry. 2OY is outperformed by 63.08% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 2OY is below the industry average of 7.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.69% | ||
| ROE | -5.77% | ||
| ROIC | 1.27% |
ROA(3y)3.48%
ROA(5y)4.48%
ROE(3y)10.49%
ROE(5y)15.16%
ROIC(3y)4.98%
ROIC(5y)6.12%
1.3 Margins
2OY's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.97%, 2OY is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of 2OY has declined.
2OY has a worse Gross Margin (8.07%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of 2OY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.97% | ||
| PM (TTM) | N/A | ||
| GM | 8.07% |
OM growth 3Y-32.39%
OM growth 5Y-11.56%
PM growth 3Y-39.18%
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5Y-6.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2OY is destroying value.
Compared to 1 year ago, 2OY has about the same amount of shares outstanding.
2OY has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 2OY is higher compared to a year ago.
2.2 Solvency
2OY has an Altman-Z score of 1.59. This is a bad value and indicates that 2OY is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.59, 2OY is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.95 indicates that 2OY is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.95, 2OY is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.59 |
ROIC/WACC0.15
WACC8.48%
2.3 Liquidity
2OY has a Current Ratio of 1.69. This is a normal value and indicates that 2OY is financially healthy and should not expect problems in meeting its short term obligations.
2OY has a Current ratio of 1.69. This is comparable to the rest of the industry: 2OY outperforms 50.77% of its industry peers.
2OY has a Quick Ratio of 1.05. This is a normal value and indicates that 2OY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.05, 2OY is in line with its industry, outperforming 46.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The earnings per share for 2OY have decreased strongly by -96.74% in the last year.
2OY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.16% yearly.
The Revenue has decreased by -2.82% in the past year.
2OY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.01% yearly.
EPS 1Y (TTM)-96.74%
EPS 3Y-42.47%
EPS 5Y-12.16%
EPS Q2Q%-161.76%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y-7.88%
Revenue growth 5Y0.01%
Sales Q2Q%-7.43%
3.2 Future
The Earnings Per Share is expected to grow by 21.05% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.25% on average over the next years.
EPS Next Y-153.94%
EPS Next 2Y-62.16%
EPS Next 3Y-6.26%
EPS Next 5Y21.05%
Revenue Next Year-5.17%
Revenue Next 2Y-1.16%
Revenue Next 3Y0.53%
Revenue Next 5Y0.25%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
2OY is valuated quite expensively with a Price/Earnings ratio of 353.33.
2OY's Price/Earnings ratio is a bit more expensive when compared to the industry. 2OY is more expensive than 60.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, 2OY is valued quite expensively.
Based on the Price/Forward Earnings ratio of 101.15, the valuation of 2OY can be described as expensive.
Based on the Price/Forward Earnings ratio, 2OY is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
2OY is valuated expensively when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 353.33 | ||
| Fwd PE | 101.15 |
4.2 Price Multiples
2OY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 2OY is cheaper than 64.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.37 |
4.3 Compensation for Growth
2OY's earnings are expected to decrease with -6.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-62.16%
EPS Next 3Y-6.26%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.86%, 2OY is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.00, 2OY pays a better dividend. On top of this 2OY pays more dividend than 92.31% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, 2OY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.86% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
The earnings of 2OY are negative and hence is the payout ratio. 2OY will probably not be able to sustain this dividend level.
DP-198.39%
EPS Next 2Y-62.16%
EPS Next 3Y-6.26%
FRA:2OY (9/12/2025, 7:00:00 PM)
21.2
+0.5 (+2.42%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners67.51%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap15.03B
Analysts64.62
Price Target25.87 (22.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.86% |
Yearly Dividend2.39
Dividend Growth(5Y)N/A
DP-198.39%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)81.78%
Min EPS beat(2)-138.3%
Max EPS beat(2)301.86%
EPS beat(4)2
Avg EPS beat(4)16.36%
Min EPS beat(4)-138.3%
Max EPS beat(4)301.86%
EPS beat(8)5
Avg EPS beat(8)11.84%
EPS beat(12)8
Avg EPS beat(12)11.61%
EPS beat(16)12
Avg EPS beat(16)10.6%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.23%
Max Revenue beat(2)0.85%
Revenue beat(4)2
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-2.23%
Max Revenue beat(4)1.19%
Revenue beat(8)4
Avg Revenue beat(8)-0.1%
Revenue beat(12)7
Avg Revenue beat(12)0.61%
Revenue beat(16)9
Avg Revenue beat(16)0.83%
PT rev (1m)-17.31%
PT rev (3m)-22.41%
EPS NQ rev (1m)-7.61%
EPS NQ rev (3m)-143.42%
EPS NY rev (1m)-1567.88%
EPS NY rev (3m)-349.04%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-8.05%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-2.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 353.33 | ||
| Fwd PE | 101.15 | ||
| P/S | 0.42 | ||
| P/FCF | N/A | ||
| P/OCF | 14.22 | ||
| P/B | 1.02 | ||
| P/tB | 2.53 | ||
| EV/EBITDA | 8.37 |
EPS(TTM)0.06
EY0.28%
EPS(NY)0.21
Fwd EY0.99%
FCF(TTM)-1.95
FCFYN/A
OCF(TTM)1.49
OCFY7.03%
SpS50.49
BVpS20.8
TBVpS8.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.69% | ||
| ROE | -5.77% | ||
| ROCE | 1.7% | ||
| ROIC | 1.27% | ||
| ROICexc | 1.34% | ||
| ROICexgc | 1.72% | ||
| OM | 1.97% | ||
| PM (TTM) | N/A | ||
| GM | 8.07% | ||
| FCFM | N/A |
ROA(3y)3.48%
ROA(5y)4.48%
ROE(3y)10.49%
ROE(5y)15.16%
ROIC(3y)4.98%
ROIC(5y)6.12%
ROICexc(3y)5.34%
ROICexc(5y)6.58%
ROICexgc(3y)7.02%
ROICexgc(5y)8.73%
ROCE(3y)6.67%
ROCE(5y)8.19%
ROICexcg growth 3Y-37.36%
ROICexcg growth 5Y-11.15%
ROICexc growth 3Y-36.83%
ROICexc growth 5Y-10.38%
OM growth 3Y-32.39%
OM growth 5Y-11.56%
PM growth 3Y-39.18%
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5Y-6.06%
F-Score2
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 97.27% | ||
| Cap/Sales | 6.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 32.91% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 1.59 |
F-Score2
WACC8.48%
ROIC/WACC0.15
Cap/Depr(3y)86.15%
Cap/Depr(5y)75.88%
Cap/Sales(3y)5.12%
Cap/Sales(5y)4.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.74%
EPS 3Y-42.47%
EPS 5Y-12.16%
EPS Q2Q%-161.76%
EPS Next Y-153.94%
EPS Next 2Y-62.16%
EPS Next 3Y-6.26%
EPS Next 5Y21.05%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y-7.88%
Revenue growth 5Y0.01%
Sales Q2Q%-7.43%
Revenue Next Year-5.17%
Revenue Next 2Y-1.16%
Revenue Next 3Y0.53%
Revenue Next 5Y0.25%
EBIT growth 1Y-58.03%
EBIT growth 3Y-37.72%
EBIT growth 5Y-11.56%
EBIT Next Year26.11%
EBIT Next 3Y26.93%
EBIT Next 5Y23.48%
FCF growth 1Y-142.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.07%
OCF growth 3Y-25.36%
OCF growth 5Y-13.25%